Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.

Ali MW, Cacan E, Liu Y, Pierce JY, Creasman WT, Murph MM, Govindarajan R, Eblen ST, Greer SF, Hooks SB.

PLoS One. 2013;8(3):e60185. doi: 10.1371/journal.pone.0060185. Epub 2013 Mar 22.

PMID:
23533674
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.

Cacan E, Ali MW, Boyd NH, Hooks SB, Greer SF.

PLoS One. 2014 Jan 27;9(1):e87455. doi: 10.1371/journal.pone.0087455. eCollection 2014.

PMID:
24475290
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.

Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM.

Mol Cancer. 2010 Nov 2;9:289. doi: 10.1186/1476-4598-9-289.

PMID:
21044322
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Regulator of G-protein signalling expression and function in ovarian cancer cell lines.

Hurst JH, Mendpara N, Hooks SB.

Cell Mol Biol Lett. 2009;14(1):153-74. doi: 10.2478/s11658-008-0040-7. Epub 2008 Oct 31.

PMID:
18979070
[PubMed - indexed for MEDLINE]
5.

Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.

Zeller C, Dai W, Steele NL, Siddiq A, Walley AJ, Wilhelm-Benartzi CS, Rizzo S, van der Zee A, Plumb JA, Brown R.

Oncogene. 2012 Oct 18;31(42):4567-76. doi: 10.1038/onc.2011.611. Epub 2012 Jan 16.

PMID:
22249249
[PubMed - indexed for MEDLINE]
6.

Histone modifications silence the GATA transcription factor genes in ovarian cancer.

Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, Xu XX.

Oncogene. 2006 Aug 31;25(39):5446-61. Epub 2006 Apr 10.

PMID:
16607277
[PubMed - indexed for MEDLINE]
7.

DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.

Meng CF, Su B, Li W.

Mol Med Rep. 2011 Nov-Dec;4(6):1273-8. doi: 10.3892/mmr.2011.557. Epub 2011 Aug 16.

PMID:
21850374
[PubMed - indexed for MEDLINE]
8.

Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.

Danam RP, Howell SR, Brent TP, Harris LC.

Mol Cancer Ther. 2005 Jan;4(1):61-9.

PMID:
15657354
[PubMed - indexed for MEDLINE]
Free Article
9.

Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.

Yeh KT, Chen TH, Yang HW, Chou JL, Chen LY, Yeh CM, Chen YH, Lin RI, Su HY, Chen GC, Deatherage DE, Huang YW, Yan PS, Lin HJ, Nephew KP, Huang TH, Lai HC, Chan MW.

Epigenetics. 2011 Jun;6(6):727-39. Epub 2011 Jun 1.

PMID:
21540640
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.

Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.

Carcinogenesis. 2004 May;25(5):693-701. Epub 2004 Jan 16.

PMID:
14729589
[PubMed - indexed for MEDLINE]
Free Article
11.

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer.

Fujisawa T, Joshi BH, Puri RK.

J Transl Med. 2011 Apr 8;9:37. doi: 10.1186/1479-5876-9-37.

PMID:
21477288
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.

Steele N, Finn P, Brown R, Plumb JA.

Br J Cancer. 2009 Mar 10;100(5):758-63. doi: 10.1038/sj.bjc.6604932.

PMID:
19259094
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Epigenetic regulation of ARHI in breast and ovarian cancer cells.

Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, Bast RC Jr.

Ann N Y Acad Sci. 2003 Mar;983:268-77. Review.

PMID:
12724231
[PubMed - indexed for MEDLINE]
14.

STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.

Li J, Cui G, Sun L, Wang SJ, Li YL, Meng YG, Guan Z, Fan WS, Li LA, Yang YZ, You YQ, Fu XY, Yan ZF, Huang K.

Oncol Rep. 2013 Jul;30(1):165-70. doi: 10.3892/or.2013.2414. Epub 2013 Apr 22.

PMID:
23604529
[PubMed - indexed for MEDLINE]
15.
16.

Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.

Yu W, Jin C, Lou X, Han X, Li L, He Y, Zhang H, Ma K, Zhu J, Cheng L, Lin B.

PLoS One. 2011;6(12):e29450. doi: 10.1371/journal.pone.0029450. Epub 2011 Dec 22.

PMID:
22216282
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.

Lyu T, Jia N, Wang J, Yan X, Yu Y, Lu Z, Bast RC Jr, Hua K, Feng W.

Epigenetics. 2013 Dec;8(12):1330-46. doi: 10.4161/epi.26675. Epub 2013 Oct 17.

PMID:
24135786
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.

Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK.

Oncogene. 2009 Jan 15;28(2):209-18. doi: 10.1038/onc.2008.374. Epub 2008 Oct 6.

PMID:
18836486
[PubMed - indexed for MEDLINE]
19.

Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.

Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.

Mol Endocrinol. 2005 Jul;19(7):1740-51. Epub 2005 Mar 3.

PMID:
15746193
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk